<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04451759</url>
  </required_header>
  <id_info>
    <org_study_id>2019-45</org_study_id>
    <nct_id>NCT04451759</nct_id>
  </id_info>
  <brief_title>Exploration by UHF MRI of Hypothalamic Networks Associated to Feeding in Obesity and Anorexia</brief_title>
  <acronym>HYPOTHALNET</acronym>
  <official_title>Exploration by UHF MRI of Hypothalamic Networks Associated to Feeding in Obesity and Anorexia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Food intake is a motivated behaviour that consists of seeking, selecting and ingesting
      nutritional resources from the environment. Its main function is therefore, depending on
      these conditions, to ensure the supply, in adequate quantities, of the energy and biochemical
      substrates necessary for the proper functioning and need of the body. Thus, in addition to
      maintaining the body's fat mass level stable, dietary behaviour is part of the energy
      homeostasis system and is thus regulated and maintained by the central nervous system.

      Although diet regulation involves several brain regions, the way in which these different
      regions communicate with each other and influence each other to orchestrate appropriate
      eating behaviour is not yet fully characterized. Among the structures of this network, the
      hypothalamus, a small structure (less than 1 cm3 in humans) composed of several nuclei such
      as the lateral hypothalamus, the arched nucleus or the lateral tuberal nucleus plays a
      crucial role.

      The investigators propose to use ultra high field (7T) magnetic resonance imaging equiping
      the CEMEREM (CHU Timone, APHM, Marseille) to better characterize the role of this crucial
      small structure in food intake networks in order to better understand the impact of these
      structural and functional disorders observed in patients with anorexia nervosa and obesity
      compared to a control population without eating behaviour disorders.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 25, 2020</start_date>
  <completion_date type="Anticipated">December 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MRI exploration conducted at 7T</measure>
    <time_frame>2 years</time_frame>
    <description>Mapping of MRI parameters of 4 sub-regions of the hypothalamus, in order to determine whether the sensitivity of quantitative T1 to 7T imaging at very high resolution can reveal microstructure variations in the 4 sub-regions of the hypothalamus in patients suffering from obesity or anorexia nervosa compared to a control population without eating disorders.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Eating Disorders</condition>
  <arm_group>
    <arm_group_label>healthy controls</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Anorexia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Obesity</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MRI exploration</intervention_name>
    <description>ultra high field (7T) magnetic resonance imaging</description>
    <arm_group_label>Anorexia</arm_group_label>
    <arm_group_label>Obesity</arm_group_label>
    <arm_group_label>healthy controls</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  No depression (HADS and BECK scores)

          -  No contraindication to 7T MRI

          -  Subject with with social insurance

          -  Subject who has signed the informed consent

        For obese patients

          -  Body mass index &gt; 30kg/m2

          -  Body diameter &lt; 60cm (compatible with 7T MR scanner tube)

        For anorexic patients

          -  mental anorexia according to DMS-V

          -  Body mass index &lt; 17kg/m2

        For healthy controls

          -  18.5kg/m2&lt;Body mass index &lt; 25kg/m2

          -  no feeding behavioral disturbance (SCOFF and EAT 26)

        Exclusion Criteria:

          -  Pregnant or parturiente woman

          -  subject with other neurological or neuropsychiatric diseases

          -  subject with addiction
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean Olivier ARNAUD</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique Hôpitaux de Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maxime Guye, MD</last_name>
    <email>maxime.guye@ap-hm.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assistance Publique Hôpitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13005</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maxime Guye, MD</last_name>
      <email>maxime.guye@ap-hm.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 22, 2020</study_first_submitted>
  <study_first_submitted_qc>June 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 30, 2020</study_first_posted>
  <last_update_submitted>July 8, 2020</last_update_submitted>
  <last_update_submitted_qc>July 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anorexia</mesh_term>
    <mesh_term>Feeding and Eating Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

